Caxton Corp as of June 30, 2018
Portfolio Holdings for Caxton Corp
Caxton Corp holds 25 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf (SPY) | 68.1 | $193M | 710k | 271.28 | |
Strongbridge Bioph shs usd | 11.4 | $32M | 5.4M | 6.00 | |
Mei Pharma | 6.1 | $17M | 4.4M | 3.94 | |
Garrison Capital | 3.2 | $9.1M | 1.1M | 8.13 | |
Cm Fin | 2.8 | $7.9M | 888k | 8.90 | |
Molecular Templates | 1.9 | $5.5M | 1.1M | 5.23 | |
Scynexis | 1.7 | $4.8M | 3.0M | 1.64 | |
Alerian Mlp Etf | 1.5 | $4.2M | 419k | 10.10 | |
Berkshire Hathaway (BRK.B) | 0.6 | $1.7M | 9.3k | 186.64 | |
Jbg Smith Properties (JBGS) | 0.5 | $1.5M | 41k | 36.46 | |
PG&E Corporation (PCG) | 0.3 | $958k | 23k | 42.58 | |
Amer (UHAL) | 0.3 | $962k | 2.7k | 356.30 | |
Tapimmune | 0.3 | $798k | 85k | 9.42 | |
Gtx Inc Del | 0.3 | $763k | 50k | 15.32 | |
Aclaris Therapeutics (ACRS) | 0.1 | $390k | 20k | 19.99 | |
Alcentra Cap | 0.1 | $354k | 55k | 6.39 | |
Triangle Capital Corporation | 0.1 | $302k | 26k | 11.49 | |
Kura Oncology (KURA) | 0.1 | $299k | 16k | 18.22 | |
Intec Pharma | 0.1 | $285k | 65k | 4.40 | |
Far Pt Acquisition Corp unit 06/01/2025 | 0.1 | $225k | 22k | 10.18 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.0 | $105k | 34k | 3.11 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $103k | 49k | 2.11 | |
Sierra Oncology | 0.0 | $100k | 34k | 2.96 | |
ArQule | 0.0 | $72k | 13k | 5.56 | |
Marinus Pharmaceuticals | 0.0 | $93k | 13k | 7.10 |